BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20799978)

  • 1. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
    Lin ZZ; Jeng YM; Hu FC; Pan HW; Tsao HW; Lai PL; Lee PH; Cheng AL; Hsu HC
    BMC Cancer; 2010 Aug; 10():461. PubMed ID: 20799978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression and amplification of Aurora-A in hepatocellular carcinoma.
    Jeng YM; Peng SY; Lin CY; Hsu HC
    Clin Cancer Res; 2004 Mar; 10(6):2065-71. PubMed ID: 15041727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue.
    Yasen M; Mizushima H; Mogushi K; Obulhasim G; Miyaguchi K; Inoue K; Nakahara I; Ohta T; Aihara A; Tanaka S; Arii S; Tanaka H
    Cancer Sci; 2009 Mar; 100(3):472-80. PubMed ID: 19134008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
    Yuan RH; Jeng YM; Hu RH; Lai PL; Lee PH; Cheng CC; Hsu HC
    J Gastrointest Surg; 2011 Feb; 15(2):321-9. PubMed ID: 21061181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
    Hu BS; Xiong SM; Li G; Li JP
    Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
    Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.
    Aihara A; Tanaka S; Yasen M; Matsumura S; Mitsunori Y; Murakata A; Noguchi N; Kudo A; Nakamura N; Ito K; Arii S
    J Hepatol; 2010 Jan; 52(1):63-71. PubMed ID: 19913935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and exon 3 mutation of beta-catenin in human hepatocellular carcinoma].
    Jiao Y; Ban KC; Cao J; Yue HY; Luo Y; Su JJ
    Ai Zheng; 2007 Oct; 26(10):1085-9. PubMed ID: 17927878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
    Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
    Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model.
    Benten D; Keller G; Quaas A; Schrader J; Gontarewicz A; Balabanov S; Braig M; Wege H; Moll J; Lohse AW; Brummendorf TH
    Neoplasia; 2009 Sep; 11(9):934-44. PubMed ID: 19724687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.
    Wong CM; Fan ST; Ng IO
    Cancer; 2001 Jul; 92(1):136-45. PubMed ID: 11443619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
    Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
    Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
    Ishibashi M; Kogo R; Shibata K; Ueo H; Uchi R; Matsumura T; Takano Y; Sawada G; Takahashi Y; Mima K; Kurashige J; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Suzuki A; Wakabayashi G; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S537-44. PubMed ID: 23532381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
    Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.